Rare diseases
Investigational molecules
Locations
2100 East 54th Street North, 57104-5509, United States
Clinical research activity is centered on Type 1 diabetes, with attention to newly diagnosed Stage 3 disease and the preservation of insulin-producing beta cells in the pancreas.
The sponsor’s work in this area reflects a therapeutic focus on slowing disease progression and addressing the underlying immune-mediated loss of pancreatic function.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
